SAM
ALXN

Storebrand Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Storebrand Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-87,133
Closed -$16M – 853
2021
Q2 		$16M Buy
87,133
+2,281
+3% +$392K 0.08% 299
2021
Q1 		$13M Buy
84,852
+8,007
+10% +$1.24M 0.07% 321
2020
Q4 		$12M Buy
76,845
+7,330
+11% +$942K 0.07% 310
2020
Q3 		$7.95M Sell
69,515
-4,332
-6% -$467K 0.06% 326
2020
Q2 		$8.29M Buy
73,847
+9,423
+15% +$1M 0.07% 291
2020
Q1 		$5.78M Buy
+64,424
New +$6.32M 0.06% 321

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return